Cochlear Ltd

COH

Company Profile

  • Business description

    Cochlear is the leading cochlear implant device manufacturer with around 60% global market share. Developed markets contribute 80% of group revenue where cochlear implants are the standard of care for children with severe to profound hearing loss. The company also actively targets the growing cohort of seniors in developed markets. Tender-oriented emerging markets contribute the remaining 20% of group revenue. Main products include cochlear implants, bone-anchored hearing aids, and associated sound processors. In fiscal 2020, 49% of revenue came from the Americas, 35% from Europe, the Middle East, and Africa, and 16% from the Asia-Pacific segment.

  • Contact

    1 University Avenue
    Macquarie University
    SydneyNSW2109
    AUS

    T: +61 294286555

    E: [email protected]

    https://www.cochlear.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    30 June 2025

    Employees

    5,155

Cochlear Ltd News & Analysis

stocks

Have these dogs of the ASX fallen too far?

Some of the ASX's worst recent performers now look cheap versus our Fair Value estimate. Others still look expensive.
video

ASX shares to own forever

Morningstar's James Gruber and Mark LaMonica discuss ASX shares to buy and hold forever.
stocks

Ahead of earnings, are these ASX shares priced for perfection?

These shares trade far above our analysts’ estimate of Fair Value. Any mishaps could result in a pullback that makes their stocks more attractive.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,634.6067.600.79%
CAC 407,213.3214.870.21%
DAX 4019,146.17141.390.74%
Dow JONES (US)43,870.35461.881.06%
FTSE 1008,149.2764.200.79%
HKSE19,601.11103.90-0.53%
NASDAQ18,972.426.280.03%
Nikkei 22538,187.05160.880.42%
NZX 50 Index12,918.97153.731.20%
S&P 5005,948.7131.600.53%
S&P/ASX 2008,391.5068.500.82%

Market Movers